HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 11 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $32,805,000 | +8.5% | 17,444,000 | 0.0% | 0.04% | +35.7% |
Q1 2022 | $30,242,000 | -0.5% | 17,444,000 | 0.0% | 0.03% | +12.0% |
Q4 2021 | $30,383,000 | +153.4% | 17,444,000 | +158.8% | 0.02% | +127.3% |
Q3 2021 | $11,988,000 | +53.2% | 6,741,000 | +68.5% | 0.01% | +57.1% |
Q2 2021 | $7,824,000 | – | 4,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WOLVERINE ASSET MANAGEMENT LLC | 33,153,000 | $58,989,000 | 0.51% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 11,250,000 | $20,091,000 | 0.46% |
SSI INVESTMENT MANAGEMENT LLC | 3,573,000 | $6,351,000 | 0.38% |
LINDEN ADVISORS LP | 10,703,000 | $19,063,000 | 0.11% |
Calamos Advisors LLC | 10,000,000 | $17,822,000 | 0.08% |
PALISADE CAPITAL MANAGEMENT, LP | 2,000,000 | $3,557,000 | 0.08% |
Hudson Bay Capital Management LP | 2,000,000 | $3,562,000 | 0.05% |
D. E. Shaw & Co., Inc. | 6,741,000 | $11,988,000 | 0.01% |
BNP PARIBAS FINANCIAL MARKETS | 3,294,000 | $5,870,620,000 | 0.01% |
FIRST HAWAIIAN BANK | 75,000 | $133,000 | 0.01% |